Skip to main content

Transplant-Free Survival and Interventions at 6 Years in the SVR Trial.

Publication ,  Conference
Newburger, JW; Sleeper, LA; Gaynor, JW; Hollenbeck-Pringle, D; Frommelt, PC; Li, JS; Mahle, WT; Williams, IA; Atz, AM; Burns, KM; Chen, S ...
Published in: Circulation
May 22, 2018

BACKGROUND: In the SVR trial (Single Ventricle Reconstruction), 1-year transplant-free survival was better for the Norwood procedure with right ventricle-to-pulmonary artery shunt (RVPAS) compared with a modified Blalock-Taussig shunt in patients with hypoplastic left heart and related syndromes. At 6 years, we compared transplant-free survival and other outcomes between the groups. METHODS: Medical history was collected annually using medical record review, telephone interviews, and the death index. The cohort included 549 patients randomized and treated in the SVR trial. RESULTS: Transplant-free survival for the RVPAS versus modified Blalock-Taussig shunt groups did not differ at 6 years (64% versus 59%, P=0.25) or with all available follow-up of 7.1±1.6 years (log-rank P=0.13). The RVPAS versus modified Blalock-Taussig shunt treatment effect had nonproportional hazards (P=0.009); the hazard ratio (HR) for death or transplant favored the RVPAS before stage II surgery (HR, 0.66; 95% confidence interval, 0.48-0.92). The effect of shunt type on death or transplant was not statistically significant between stage II to Fontan surgery (HR, 1.36; 95% confidence interval, 0.86-2.17; P=0.17) or after the Fontan procedure (HR, 0.76; 95% confidence interval, 0.33-1.74; P=0.52). By 6 years, patients with RVPAS had a higher incidence of catheter interventions (0.38 versus 0.23/patient-year, P<0.001), primarily because of more interventions between the stage II and Fontan procedures (HR, 1.72; 95% confidence interval, 1.00-3.03). Complications did not differ by shunt type; by 6 years, 1 in 5 patients had had a thrombotic event, and 1 in 6 had had seizures. CONCLUSIONS: By 6 years, the hazards of death or transplant and catheter interventions were not different between the RVPAS versus modified Blalock-Taussig shunt groups. Children assigned to the RVPAS group had 5% higher transplant-free survival, but the difference did not reach statistical significance, and they required more catheter interventions. Both treatment groups have accrued important complications. CLINICAL TRIAL REGISTRATION: URL: https://www.clinicaltrials.gov. Unique identifier: NCT00115934.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

May 22, 2018

Volume

137

Issue

21

Start / End Page

2246 / 2253

Location

United States

Related Subject Headings

  • Thrombosis
  • Seizures
  • Pulmonary Artery
  • Proportional Hazards Models
  • Norwood Procedures
  • Kaplan-Meier Estimate
  • Interviews as Topic
  • Infant
  • Hypoplastic Left Heart Syndrome
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Newburger, J. W., Sleeper, L. A., Gaynor, J. W., Hollenbeck-Pringle, D., Frommelt, P. C., Li, J. S., … Pediatric Heart Network Investigators, . (2018). Transplant-Free Survival and Interventions at 6 Years in the SVR Trial. In Circulation (Vol. 137, pp. 2246–2253). United States. https://doi.org/10.1161/CIRCULATIONAHA.117.029375
Newburger, Jane W., Lynn A. Sleeper, J William Gaynor, Danielle Hollenbeck-Pringle, Peter C. Frommelt, Jennifer S. Li, William T. Mahle, et al. “Transplant-Free Survival and Interventions at 6 Years in the SVR Trial.” In Circulation, 137:2246–53, 2018. https://doi.org/10.1161/CIRCULATIONAHA.117.029375.
Newburger JW, Sleeper LA, Gaynor JW, Hollenbeck-Pringle D, Frommelt PC, Li JS, et al. Transplant-Free Survival and Interventions at 6 Years in the SVR Trial. In: Circulation. 2018. p. 2246–53.
Newburger, Jane W., et al. “Transplant-Free Survival and Interventions at 6 Years in the SVR Trial.Circulation, vol. 137, no. 21, 2018, pp. 2246–53. Pubmed, doi:10.1161/CIRCULATIONAHA.117.029375.
Newburger JW, Sleeper LA, Gaynor JW, Hollenbeck-Pringle D, Frommelt PC, Li JS, Mahle WT, Williams IA, Atz AM, Burns KM, Chen S, Cnota J, Dunbar-Masterson C, Ghanayem NS, Goldberg CS, Jacobs JP, Lewis AB, Mital S, Pizarro C, Eckhauser A, Stark P, Ohye RG, Pediatric Heart Network Investigators. Transplant-Free Survival and Interventions at 6 Years in the SVR Trial. Circulation. 2018. p. 2246–2253.

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

May 22, 2018

Volume

137

Issue

21

Start / End Page

2246 / 2253

Location

United States

Related Subject Headings

  • Thrombosis
  • Seizures
  • Pulmonary Artery
  • Proportional Hazards Models
  • Norwood Procedures
  • Kaplan-Meier Estimate
  • Interviews as Topic
  • Infant
  • Hypoplastic Left Heart Syndrome
  • Humans